CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
-8.28%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$282M
AUM Growth
+$282M
(-33%)
Cap. Flow
-$90.8M
Cap. Flow
% of AUM
-32.15%
Top 10 Holdings %
Top 10 Hldgs %
39.72%
Holding
104
New
12
Increased
14
Reduced
39
Closed
18
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$8.36M |
| 2 |
Walmart
WMT
|
$4.66M |
| 3 |
Procter & Gamble
PG
|
$4.25M |
| 4 |
ON Semiconductor
ON
|
$3.38M |
| 5 |
CVS Health
CVS
|
$2.92M |
Top Sells
| 1 |
Microsoft
MSFT
|
$17.8M |
| 2 |
Apple
AAPL
|
$15.8M |
| 3 |
NetEase
NTES
|
$9.57M |
| 4 |
Qualcomm
QCOM
|
$6.68M |
| 5 |
Pinduoduo
PDD
|
$6.24M |
Sector Composition
| 1 | Technology | 44.63% |
| 2 | Healthcare | 20.93% |
| 3 | Consumer Discretionary | 14.32% |
| 4 | Communication Services | 7.93% |
| 5 | Consumer Staples | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Repligen
RGEN
$6.76B
| $1.68M | 0.6% |
8,939
-11,933
| -57% | -$2.24M |
|
52
Analog Devices
ADI
$122B
| $1.65M | 0.58% |
+10,000
| New | +$1.65M |
|
53
STMicroelectronics
STM
$23.3B
| $1.38M | 0.49% |
32,000
-21,500
| -40% | -$929K |
|
54
Snap
SNAP
$12.3B
| $1.33M | 0.47% |
37,000
-30,000
| -45% | -$1.08M |
|
55
New Oriental
EDU
$8.04B
| $1.15M | 0.41% |
+1,000,000
| New | +$1.15M |
|
56
DocuSign
DOCU
$15B
| $1.07M | 0.38% |
10,000
| – | – |
|
57
Idexx Laboratories
IDXX
$51.1B
| $1.06M | 0.37% |
1,929
-4,346
| -69% | -$2.38M |
|
58
Charles River Laboratories
CRL
$7.91B
| $913K | 0.32% |
3,214
-5,297
| -62% | -$1.5M |
|
59
10x Genomics
TXG
$1.65B
| $712K | 0.25% |
9,359
-9,722
| -51% | -$740K |
|
60
Booking.com
BKNG
$178B
| $697K | 0.25% |
+297
| New | +$697K |
|
61
Edwards Lifesciences
EW
$48B
| $695K | 0.25% |
5,901
-3,797
| -39% | -$447K |
|
62
BioMarin Pharmaceuticals
BMRN
$11.3B
| $529K | 0.19% |
+6,860
| New | +$529K |
|
63
Wolfspeed
WOLF
$202M
| $458K | 0.16% |
4,020
-22,898
| -85% | -$2.61M |
|
64
Alibaba
BABA
$329B
| $429K | 0.15% |
+3,947
| New | +$429K |
|
65
BioNTech
BNTX
$24.2B
| $392K | 0.14% |
2,298
| – | – |
|
66
Eli Lilly
LLY
$659B
| $381K | 0.13% |
1,331
-13,141
| -91% | -$3.76M |
|
67
Illumina
ILMN
$15.4B
| $316K | 0.11% |
905
| – | – |
|
68
lululemon athletica
LULU
$23.9B
| $278K | 0.1% |
762
-5,309
| -87% | -$1.94M |
|
69
IQVIA
IQV
$31.2B
| $202K | 0.07% |
873
| – | – |
|
70
Align Technology
ALGN
$9.91B
| $190K | 0.07% |
435
-2,884
| -87% | -$1.26M |
|
71
Moderna
MRNA
$9.39B
| $166K | 0.06% |
966
| – | – |
|
72
Ginkgo Bioworks
DNA
$657M
| $120K | 0.04% |
29,813
-217,172
| -88% | -$874K |
|
73
CRISPR Therapeutics
CRSP
$4.8B
| $84K | 0.03% |
+1,333
| New | +$84K |
|
74
Netflix
NFLX
$515B
| $57K | 0.02% |
153
| – | – |
|
75
Guardant Health
GH
$8.28B
| $38K | 0.01% |
581
| – | – |
|